Latest Conference Articles

The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.

Elizabeth Blasiak Discusses the ONS Congress

May 6th 2011, 7:00am

Oncology Nursing Society Congress

Elizabeth Blasiak on the Significance of the ONS Congress

Changing Paradigms-Integrating Novel Therapeutics Into the Standard of Care

April 18th 2011, 10:20am

Interdisciplinary Prostate Cancer Congress

Prostate cancer affects 1 of every 6 men in the United States

Considerations for Integrating Chemotherapy

April 18th 2011, 10:08am

Interdisciplinary Prostate Cancer Congress

Traditional, linear regimen of prostate cancer treatment may need to be reexamined as oncologists learn new ways to incorporate new therapies

Bone-Targeted Therapeutics

April 18th 2011, 10:03am

Interdisciplinary Prostate Cancer Congress

Initial clinical findings indicate that results with radiotherapies sometime improve when combined with immunotherapy

Immunotherapies: Avoiding collisions once the brake is released

April 13th 2011, 7:09am

Interdisciplinary Prostate Cancer Congress

Immunotherapies again made headlines in oncology last month

Novel Hormone-Radiation Therapy Approaches

April 12th 2011, 6:07am

Interdisciplinary Prostate Cancer Congress

Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized high-risk prostate cancer patients

PSA: To Screen or Not to Screen

April 12th 2011, 5:56am

Interdisciplinary Prostate Cancer Congress

Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella

Integrating New Hormonal Therapies in Advanced Disease

April 11th 2011, 12:12pm

Interdisciplinary Prostate Cancer Congress

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Novel vaccine approaches: Prospects for PROSTVAC®-VF are bright

April 11th 2011, 12:03pm

Interdisciplinary Prostate Cancer Congress

As research into novel vaccine approaches for treating advanced prostate cancer continues...

The Overtreatment of Prostate Cancer

April 11th 2011, 11:59am

Interdisciplinary Prostate Cancer Congress

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

Breast Reconstruction Trainee Assessment

March 18th 2011, 2:04pm

PER® Miami Breast Cancer Conference

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Osman on Designing the Program for the MBCC

March 16th 2011, 12:25pm

PER® Miami Breast Cancer Conference

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Dr. Fazel on Trends in Surgical Training

March 14th 2011, 1:56pm

PER® Miami Breast Cancer Conference

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Need for Survivorship Plans Emphasized

March 14th 2011, 5:08am

PER® Miami Breast Cancer Conference

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative Therapy Offers Value to Patients

March 14th 2011, 5:07am

PER® Miami Breast Cancer Conference

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

Framework for Evaluating Trial Results Detailed

March 14th 2011, 5:04am

PER® Miami Breast Cancer Conference

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Genomic Profiles as Routine Care Are a Hot Topic

March 14th 2011, 5:02am

PER® Miami Breast Cancer Conference

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized Treatment With Adjuvant Chemotherapy Shows Marginal Progress

March 14th 2011, 5:00am

PER® Miami Breast Cancer Conference

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive